Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cognitive Enhancement in Depression (The COG-D Study)

NCT: NCT05400512 · COMPLETED

NCT IDNCT05400512
StatusCOMPLETED
Start Date2023-02-08
Completion2025-08-18
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

Brief Summary

This study will investigate whether transcranial direct current stimulation (tDCS) enhances the effects of computerized cognitive training in older adults with recurrent depression (2 or more lifetime episodes; either current or within past 3 years).

Frequently Asked Questions

What is Cognitive Enhancement in Depression (The COG-D Study)?

Cognitive Enhancement in Depression (The COG-D Study) is a clinical trial registered under NCT05400512. Current status: COMPLETED.

What is the status of NCT05400512?

The current status of NCT05400512 (Cognitive Enhancement in Depression (The COG-D Study)) is: COMPLETED.

When did Cognitive Enhancement in Depression (The COG-D Study) start?

Cognitive Enhancement in Depression (The COG-D Study) started on 2023-02-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑